AJP - Heart Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 279: H1661-H1668, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jo, S.-H.
Right arrow Articles by Lee, C. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jo, S.-H.
Right arrow Articles by Lee, C. O.
Vol. 279, Issue 4, H1661-H1668, October 2000

Role of protein kinase C in alpha 1-adrenergic regulation of aNai in guinea pig ventricular myocytes

Su-Hyun Jo1, Chung-Hyun Cho1, Soo Wan Chae2, and Chin O. Lee1

1 Department of Life Science, Pohang University of Science and Technology, Pohang 790-784; and 2 Department of Pharmacology, Chonbuk National University Medical School, Chonju 560-180, Republic of Korea

We investigated the role of protein kinase C (PKC) in alpha 1-adrenergic regulation of intracellular Na+ activity (aNai) in single guinea pig ventricular myocytes. aNai and membrane potentials were measured with the Na+-sensitive indicator sodium-binding benzofuran isophthalate and conventional microelectrodes, respectively, at room temperature (24-26°C) while myocytes were stimulated at a rate of 0.25-0.3 Hz. The PKC activator 4beta -phorbol 12-myristate 13-acetate (PMA) decreased aNai in a concentration-dependent manner. PMA (100 nM) produced a maximal decrease in aNai of 1.5 mM from 6.5 ± 0.4 to 5.0 ± 0.4 mM (means ± SE, n = 12, P < 0.01). The PMA concentration required for a half-maximal decrease in aNai was 0.46 ± 0.13 nM (n = 3, P < 0.01). An inactive phorbol, 4alpha -phorbol 12-myristate 13-acetate, did not decrease aNai. The decrease caused by PMA could be blocked by the PKC inhibitors staurosporine and bisindolylmaleimide I (GF-109203X). Stimulation of the alpha 1-adrenoceptor with 50 µM phenylephrine decreased aNai from 6.1 ± 0.3 to 4.6 ± 0.3 mM (n = 11, P < 0.01). The decrease in aNai produced by phenylephrine was blocked by pretreatment with staurosporine, GF-109203X, or PMA. The decrease in aNai produced by PMA was not prevented by pretreatment with tetrodotoxin but was blocked by pretreatment with strophanthidin or high extracellular K+ concentration. The results suggest that alpha 1-adrenergic receptor activation results in a decrease in aNai via PKC-induced stimulation of the Na+-K+ pump in cardiac myocytes.

alpha 1-adrenergic receptor; phenylephrine; phorbol 12-myristate 13-acetate; sodium-potassium ion pump; intracellular sodium ion activity





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online